Author Archive: Jim Greenwood

Jim Greenwood

Jim joined BIO as President & CEO in 2005 after representing the eighth district of Pennsylvania in the U.S. House of Representatives for six terms.  He had worked with BIO while in Congress on stem cell research and other health issues, and has since learned so much about the many applications of the science in food and agriculture and in industrial and environmental biotechnology.

Due to its revolutionary research and development in issues ranging from feeding the world by increasing crop yields to healing the world with new medicines to providing cleaner sources of energy, Jim is a passionate champion for biotechnology. When visiting member companies, he is inspired by executives and scientists who are united in their mission to help patients, farmers and other consumers lead a better life.

Prior to Congress, Jim served in the Pennsylvania House of Representatives and Pennsylvania Senate for six years each.  He and his wife Tina live in historic Washington Crossing, Pennsylvania (where he has participated in the re-enactment of George Washington crossing the Delaware River on Christmas Day in 1776). He enjoys fishing, birding and scuba diving.

You can find him on Facebook at https://www.facebook.com/jamescgreenwood.

Latest Posts

Welcome to San Diego!

Jim Greenwood

Welcome to the 2014 BIO International Convention. It has been an exciting and important year for our industry. Since we last met, we have seen record IPOs, important new approvals, exciting scientific advances and hard fought policy victories in Washington, DC and the states. But we all know that accomplishments don’t just happen by luck. They are the result of decades of hard work, long hours and repeated setbacks. So while it’s important to celebrate Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO and Biominas Brasil to Co-Host 2014 BIO Latin America Conference

Jim Greenwood

I am excited to announce that BIO will co-host a new conference event, BIO Latin America, taking place September 9-11, 2014, in Rio de Janeiro, Brazil.  We recently entered into an agreement with Biominas Brasil, a not-for- profit institution dedicated to life sciences in the region, to build on the successful BioPartnering Latin America event held by Biominas the past four years.  This new international conference for BIO will complement our global portfolio of industry events. The decision Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Biotech Investors, Emerging Companies Bullish On 2014

Jim Greenwood

The 16th BIO CEO & Investor Conference is off to a great start. This event has truly grown into a must attend for emerging companies and investors. This year, we have more than 1,300 participants, including more than 850 investors. In addition, we have helped to set up more than 1,700 partnering meetings for participants over the course of the conference. Our world-class partnering system, and the opportunity to hear from key industry leaders, is Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,

Stable Policy Can Help Assure Unwavering Investment in U.S. Biofuels

Jim Greenwood

The Renewable Fuel Standard (RFS) is a unique federal policy that has, just as its bipartisan supporters intended, spurred major domestic and international investment in US biofuels production and it is essential to maintaining a growing market for second generation biofuels. That growing market helps attract investment to advanced biofuel companies who are trying to expand their infrastructure, scale up their production line, and improve their technology foundation. Unfortunately, the Environmental Protection Agency’s (EPA) recent Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Ask CA Governor Brown To Sign SB 598

Jim Greenwood

California’s Assembly and Senate have both overwhelmingly passed Senate Bill 598, legislation that creates a pathway for the substitution of interchangeable biologic medicines. Despite fierce opposition from insurance companies and large pharmacy chains, it is now on its way to the Governor’s desk. It’s critical for him to understand that this issue is one of the highest priorities for patients, healthcare providers and the life sciences industry. Senate Bill 598 is needed now to update Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , ,